FAA Pushes for Further Flight Reductions at Chicago O’Hare Ahead of Busy Summer 2026 
U.S. Pulls Back Proposed AI Chip Export Rule Amid Policy Uncertainty 
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 
Taiwan Strengthens Deterrence Amid Ongoing Chinese Military Threat 
Israel Doubles Troops at Lebanon Border, Searches Evacuated Villages 
DOJ Backs Jeanine Pirro-Led Investigation Into Federal Reserve Chair Jerome Powell 
Big Tech Signs White House Pledge to Fund Power for AI Data Centers 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some 
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes 
Trump Eyes Troop Deployment to Middle East Amid Escalating Iran Conflict 
Costa Rica Cuts Diplomatic Ties with Cuba Amid Growing U.S. Pressure 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
Trump Administration Proposes Tough AI Contract Rules as Anthropic Blacklisted by Pentagon 
Japan's Military Options in the Strait of Hormuz: What Tokyo Can and Cannot Do 
Venezuela Appoints New Defense Minister as Rodriguez Reshapes Military Leadership 
The United States is moving closer to naming a permanent leader for the Centers for Disease Control and Prevention, according to a top health official. Chris Klomp, chief counselor at the Department of Health and Human Services, expressed strong confidence following a series of interviews with potential candidates for the CDC director role.
"I'm very optimistic that we will select an excellent leader for that agency," Klomp stated during a Stat News health conference, signaling that the selection process is well underway.
The CDC has been operating under a succession of acting directors since former director Susan Monarez was dismissed last August after opposing vaccine policy changes proposed by Health Secretary Robert F. Kennedy Jr. Jim O'Neill briefly stepped in as acting director before being replaced by NIH Director Jay Bhattacharya following a leadership restructuring last month.
Kennedy's sweeping vaccine policy reforms have significantly disrupted the nation's public health infrastructure. A federal judge recently issued a temporary block on major components of those changes, including most of Kennedy's appointments to the CDC's vaccine advisory committee and proposed updates to childhood immunization recommendations. The HHS has since announced plans to appeal the ruling.
Adding further complexity, advisory committee member Dr. Robert Malone suggested via social media that the panel would be dissolved and reconstituted to sidestep a prolonged legal battle. However, an HHS spokesperson cautioned that any unofficial statements about next steps remain speculative until formally announced.
Legal pressure continues to mount. The American Academy of Pediatrics, which filed the original lawsuit challenging Kennedy's vaccine policies, made clear it will contest any committee restructuring that fails to meet proper legal and procedural standards.
As public health stakeholders await the appointment of a permanent CDC director, the agency's stability and its vaccine advisory framework remain central issues shaping the future of U.S. health policy.
